EUR 0.8
(-1.23%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 96.83 Million EUR | 16.29% |
2022 | 83.26 Million EUR | 0.77% |
2021 | 82.62 Million EUR | 58.85% |
2020 | 52.01 Million EUR | 29.37% |
2019 | 40.2 Million EUR | 146.81% |
2018 | 16.29 Million EUR | 28.87% |
2017 | 12.64 Million EUR | 46.98% |
2016 | 8.6 Million EUR | 18.69% |
2015 | 7.24 Million EUR | 15.43% |
2014 | 6.27 Million EUR | -57.46% |
2013 | 14.75 Million EUR | 51.25% |
2012 | 9.75 Million EUR | -7.4% |
2011 | 10.53 Million EUR | 89.66% |
2010 | 5.55 Million EUR | 180.91% |
2009 | 1.97 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 76.71 Million EUR | 0.0% |
2023 Q4 | 96.83 Million EUR | 0.0% |
2023 Q2 | 89.02 Million EUR | 0.0% |
2023 FY | 96.83 Million EUR | 16.29% |
2022 Q2 | 80.83 Million EUR | 0.0% |
2022 FY | 83.26 Million EUR | 0.77% |
2022 Q4 | 83.26 Million EUR | 0.0% |
2021 FY | 82.62 Million EUR | 58.85% |
2021 Q2 | 67.78 Million EUR | 0.0% |
2021 Q4 | 82.62 Million EUR | 0.0% |
2020 Q4 | 52.01 Million EUR | 0.0% |
2020 Q2 | 53.55 Million EUR | 0.0% |
2020 FY | 52.01 Million EUR | 29.37% |
2019 Q2 | 40.3 Million EUR | 0.0% |
2019 Q4 | 40.2 Million EUR | 0.0% |
2019 FY | 40.2 Million EUR | 146.81% |
2018 FY | 16.29 Million EUR | 28.87% |
2018 Q2 | 12.41 Million EUR | 0.0% |
2018 Q4 | 16.29 Million EUR | 0.0% |
2017 FY | 12.64 Million EUR | 46.98% |
2017 Q4 | 12.64 Million EUR | 0.0% |
2017 Q2 | 9.77 Million EUR | 0.0% |
2016 Q2 | 7.74 Million EUR | 0.0% |
2016 Q4 | 8.6 Million EUR | 0.0% |
2016 FY | 8.6 Million EUR | 18.69% |
2015 Q2 | 6.04 Million EUR | 0.0% |
2015 FY | 7.24 Million EUR | 15.43% |
2015 Q4 | 7.24 Million EUR | 0.0% |
2014 Q2 | 6.93 Million EUR | 0.0% |
2014 Q4 | 6.27 Million EUR | 0.0% |
2014 FY | 6.27 Million EUR | -57.46% |
2013 Q4 | 14.75 Million EUR | 0.0% |
2013 FY | 14.75 Million EUR | 51.25% |
2013 Q2 | 9.72 Million EUR | 0.0% |
2012 FY | 9.75 Million EUR | -7.4% |
2012 Q2 | 9.34 Million EUR | 0.0% |
2012 Q4 | 9.75 Million EUR | 0.0% |
2011 FY | 10.53 Million EUR | 89.66% |
2011 Q2 | 6.52 Million EUR | 0.0% |
2011 Q4 | 10.53 Million EUR | 0.0% |
2010 Q2 | 6.58 Million EUR | 0.0% |
2010 Q4 | 5.55 Million EUR | 0.0% |
2010 FY | 5.55 Million EUR | 180.91% |
2009 FY | 1.97 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Affluent Medical SA | 25.15 Million EUR | -284.999% |
Bluelinea Société Anonyme | 8.86 Million EUR | -992.321% |
Diagnostic Medical Systems S.A. | 37.41 Million EUR | -158.796% |
Euromedis Groupe | 23.66 Million EUR | -309.139% |
Eurobio Scientific Société anonyme | 141.15 Million EUR | 31.402% |
Ikonisys S.A. | 5.11 Million EUR | -1791.249% |
Implanet S.A. | 10.81 Million EUR | -795.671% |
Median Technologies SA | 46.22 Million EUR | -109.464% |
SpineGuard SA | 5 Million EUR | -1835.303% |
Theraclion SA | 13.01 Million EUR | -643.906% |
Euroapi S.A. | 684.7 Million EUR | 85.858% |
Guerbet SA | 646.97 Million EUR | 85.033% |